Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Accentia forms strategic alliance with Baxter

Dec. 1, 2010

Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies

Dec. 1, 2010

Immunovaccine and OncoTherapy Science join to develop cancer vaccine

Dec. 1, 2010

IntelGenx acquires rights to INT-0010 formulation of dronabinol

Nov. 30, 2010

Worldwide rights to pegsiticase acquired by 3SBio from EnzymeRx

Nov. 30, 2010

Medgenics extends Factor VIII Biopump collaboration

Nov. 30, 2010

Selcia and Gilead to continue liver disease drug discovery collaboration

Nov. 29, 2010

Merrion and Rebel Pharma enter into feasibility and option agreement

Nov. 29, 2010

Covidian licenses drug delivery platform technology from UBC and CDRD

Nov. 26, 2010

Advanced Proteome Therapeutics enters agreement to advance its SLMT platform

Nov. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
Initial data hint that US MFN pricing is hitting access in Europe
BioWorld
There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...